MedTrace Logo

Fecal Microbiota Transplant by Oral Capsules With Lactobacilli for Recurrent Clostridium Difficile Infection

NCT03804736 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2019-03-05

No results posted yet for this study

Summary

Investigators designed an open, two-arm study to compare fecal microbiota transplant by oral capsules (FMT-c ) versus FMT-c enriched with Lactobacillus for treatment of C. difficile recurrent infection

Conditions

  • Clostridium Difficile Infection

Interventions

BIOLOGICAL

FMT-c

Patients in the FMT-c receive FMT-c (15 capsules every 12 h for 2 days)

BIOLOGICAL

FMT-c Lactobacillus

Patients in the FMT-c Lactobacillus receive FMT-c Lactobacillus (15 capsules every 12 h for 2 days)

Sponsors & Collaborators

  • Universidad Autonoma de Nuevo Leon

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-01
Primary Completion
2018-06-30
Completion
2019-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03804736 on ClinicalTrials.gov